Company intelligence / Profile preview

Stendhal Pharma

Mexico City, Ciudad de México, Mexico

Ownership: Private
Employees: ~274
Development stage: Other

Overview

Stendhal is an established commercial-stage pharmaceutical company operating across Latin America with a focus on specialty therapeutics including HIV/AIDS, multiple sclerosis, oncology, and rare diseases

Therapeutic areas: CardiovascularNeurologyInfectious DiseasesRare DiseasesPsychiatryOncology
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

Servier

Beyond the preview

Go deeper on Stendhal Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stendhal Pharma.

Explore the full profile